recombinant human vegf a165 (MedChemExpress)
94
Structured Review
MedChemExpress
recombinant human vegf a165
Recombinant Human Vegf A165, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+vegf/VEGF165%2C+Human/pmc13463935-118-5-9
Average 94 stars, based on 2 article reviews
Recombinant Human Vegf A165, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+vegf/VEGF165%2C+Human/pmc13463935-118-5-9
Average 94 stars, based on 2 article reviews
recombinant human vegf a165 - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Transfection:Article Title: NOL7 Inhibits Ovarian Cancer Progression and Suppresses Angiogenesis by Stabilizing GADD45A to Deactivate STAT3. Article Snippet: .. For angiogenesis assays, HUVECs were stimulated with conditioned medium from OVCAR- 3 and SKOV- 3 cells transfected with NOL7 wild type (WT) plasmids for 24 h. For functional validation of VEGF and TSP- 1, HUVECs were treated with conditioned medium from OVCAR- 3 and SKOV- 3 cells, combined with 200 pg/mL Functional Assay:Article Title: NOL7 Inhibits Ovarian Cancer Progression and Suppresses Angiogenesis by Stabilizing GADD45A to Deactivate STAT3. Article Snippet: .. For angiogenesis assays, HUVECs were stimulated with conditioned medium from OVCAR- 3 and SKOV- 3 cells transfected with NOL7 wild type (WT) plasmids for 24 h. For functional validation of VEGF and TSP- 1, HUVECs were treated with conditioned medium from OVCAR- 3 and SKOV- 3 cells, combined with 200 pg/mL Biomarker Discovery:Article Title: NOL7 Inhibits Ovarian Cancer Progression and Suppresses Angiogenesis by Stabilizing GADD45A to Deactivate STAT3. Article Snippet: .. For angiogenesis assays, HUVECs were stimulated with conditioned medium from OVCAR- 3 and SKOV- 3 cells transfected with NOL7 wild type (WT) plasmids for 24 h. For functional validation of VEGF and TSP- 1, HUVECs were treated with conditioned medium from OVCAR- 3 and SKOV- 3 cells, combined with 200 pg/mL Recombinant:Article Title: NOL7 Inhibits Ovarian Cancer Progression and Suppresses Angiogenesis by Stabilizing GADD45A to Deactivate STAT3. Article Snippet: .. For angiogenesis assays, HUVECs were stimulated with conditioned medium from OVCAR- 3 and SKOV- 3 cells transfected with NOL7 wild type (WT) plasmids for 24 h. For functional validation of VEGF and TSP- 1, HUVECs were treated with conditioned medium from OVCAR- 3 and SKOV- 3 cells, combined with 200 pg/mL |